Here, our findings indicated that LRP1 might participate in regulating the TJ barrier in human keratinocytes and in mice with DNCB-induced dermatitis-like lesions, because AMP-IBP5 failed to ameliorate AD in RAP-treated keratinocytes and AD mice. The gene discussed is LRP1; the disease is skin disorder.